- Home
- CNSP vs VERO Comparison
CNSP vs VERO Comparison
Compare CNSP & VERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNSP
- VERO
- Stock Information
- Founded
- CNSP 2017
- VERO N/A
- Country
- CNSP United States
- VERO Canada
- Employees
- CNSP N/A
- VERO N/A
- Industry
- CNSP Biotechnology: Pharmaceutical Preparations
- VERO Medical/Dental Instruments
- Sector
- CNSP Health Care
- VERO Health Care
- Exchange
- CNSP Nasdaq
- VERO Nasdaq
- Market Cap
- CNSP 4.0M
- VERO 4.0M
- IPO Year
- CNSP 2019
- VERO N/A
- Fundamental
- Price
- CNSP $7.20
- VERO $1.88
- Analyst Decision
- CNSP Strong Buy
- VERO
- Analyst Count
- CNSP 1
- VERO 0
- Target Price
- CNSP $20.00
- VERO N/A
- AVG Volume (30 Days)
- CNSP 13.8K
- VERO 1.8M
- Earning Date
- CNSP 11-17-2025
- VERO 11-13-2025
- Dividend Yield
- CNSP N/A
- VERO N/A
- EPS Growth
- CNSP N/A
- VERO N/A
- EPS
- CNSP N/A
- VERO N/A
- Revenue
- CNSP N/A
- VERO $58,876,000.00
- Revenue This Year
- CNSP N/A
- VERO N/A
- Revenue Next Year
- CNSP N/A
- VERO $10.00
- P/E Ratio
- CNSP N/A
- VERO N/A
- Revenue Growth
- CNSP N/A
- VERO N/A
- 52 Week Low
- CNSP $4.93
- VERO $1.65
- 52 Week High
- CNSP $114.00
- VERO $14.50
- Technical
- Relative Strength Index (RSI)
- CNSP 46.98
- VERO 46.50
- Support Level
- CNSP $6.30
- VERO $1.72
- Resistance Level
- CNSP $7.07
- VERO $2.13
- Average True Range (ATR)
- CNSP 0.59
- VERO 0.24
- MACD
- CNSP 0.06
- VERO 0.01
- Stochastic Oscillator
- CNSP 34.80
- VERO 19.71
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.
About VERO Venus Concept Inc.
Venus Concept Inc is a medical technology company. It develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies and related services. The company's products include NeoGraft, Venus Viva, Venus Legacy, Venus Versa, Venus Velocity, Venus Bliss, ARTAS systems, and others. The company provides medical devices and treatments for hair, body, and skin-related problems. It generates a majority of its revenue from the United States.